.S. Biodefense, Inc. (OTCBB: UBDE) - Friday's shares went down 3.06% to $0.0950 with a total of 154,245 shares traded. On Aug. 22, David Chin, CEO of U.S. BioDefense, Inc. announced the appointment of Charles Wright as the company's Executive Vice President. Charles Wright will assist with the development and expansion of Emergency Disaster Systems' sale team and the overall direction of U.S. BioDefense's business development and marketing efforts. "The addition of Mr. Wright, with over 19 years of experience in the emergency disaster preparedness industry, is a significant addition to U.S. BioDefense's management team and a solid compliment to the direction and growth of the company. This is the first step toward forming a strong board of directors that will lead the company to explore new opportunities and build upon its existing infrastructure," said David Chin, CEO of U.S. BioDefense. "Joining U.S. BioDefense will allow me to capitalize on my experience and utilize my close network of advisors and consultants to maximize the growth potential of the company. In turn, the company's resources will allow me to more fully develop already proven strategies to increase sales and sustain growth for Emergency Disaster Systems," commented Charles Wright, U.S. BioDefense Executive Vice President.
U.S. BioDefense is a Department of Defense central contractor that researches, develops, and commercializes leading-edge biotechnology. U.S. BioDefense, Inc. is focused on transferring, researching, and commercializing groundbreaking technology from Universities, Research Labs, Fortune 500 Companies, and Government Agencies. U.S. BioDefense subsidiary, Stem Cell Research Institute, Inc., is focused on the commercialization of breakthrough Stem Cell technologies. U.S. BioDefense is forming a Stem Cell Center of Excellence consisting of Medical Advisors to transfer, research, develop, fund, and commercialize technology in California, and has submitted applications for several major Grants provided by the United States Department of Defense's Chemical Biological Defense Agency and the National Institute of Health based on its Stem Cell technologies.
For a quote and the latest news on this company, please visit: http://www.stockguru.com/profiles/UBDE.php .
